Ashland Inks Deal to Sell Avoca Business to Optimize Portfolio
Werte in diesem Artikel
Ashland Inc. ASH announced that it has signed a definitive agreement to sell its Avoca business to Mane. ASH disclosed that it is reviewing strategic alternatives for the underperforming Avoca business line. This is in sync with ASH’s efforts to optimize its portfolio, focus on core operations and improve margins.Avoca supplies Sclareolide, a fragrance fixative and a range of contract manufacturing capabilities. It has two production facilities in North Carolina and Wisconsin. Ashland had acquired Avoca business line part of the Pharmachem acquisition. Ashland noted that the Avoca business remained challenged over the past few quarters as customers have moved from plant-based to lower-cost bio-based materials. The company recently exited as an unprofitable tolling operation at Avoca and had reduced workforce at a larger facility in response to lower demand. The transaction is expected to close in the first quarter of 2025.For fiscal 2025, Ashland expects sales to be in the range of $1.90 billion to $2.05 billion and adjusted EBITDA to be in the range of $430 million to $470 million. ASH expects to grow volumes in fiscal 2025 to offset increased pricing competition.Ashland Stock’s Price PerformanceThe ASH stock has plunged 15.1% in the past year compared with the 20.6% decline in the industry.Image Source: Zacks Investment ResearchASH’s Zacks Rank and Key PicksASH currently carries a Zacks Rank #4 (Sell).Some better-ranked stocks in the Basic Materials space are Carpenter Technology Corporation CRS, CF Industries Holdings, Inc. CF and ICL Group Ltd ICL. While CRS sports a Zacks Rank #1 (Strong Buy) at present, CF and ICL carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Carpenter Technology’s current-year earnings is pegged at $6.74 per share. CRS’ earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and matched once, with the average surprise being 14.1%. The company’s shares have gained 141% in the past year.The Zacks Consensus Estimate for CF Industries’ current year earnings is pegged at $6.36 per share. CF surpassed the Zacks Consensus Estimate twice in the trailing four quarters and missed the rest, with an average earnings surprise of 10.3%. The stock has gained 6.6% in the past year.The Zacks Consensus Estimate for ICL’s current-year earnings is pegged at 35 cents. ICL’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 18.1%.Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CF Industries Holdings, Inc. (CF): Free Stock Analysis Report Ashland Inc. (ASH): Free Stock Analysis Report Carpenter Technology Corporation (CRS): Free Stock Analysis Report ICL Group Ltd. (ICL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Ashland Global
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ashland Global
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Ashland Global Holdings Inc
Analysen zu Ashland Global Holdings Inc
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Ashland Global Outperform | BMO Capital Markets | |
31.01.2018 | Ashland Global Neutral | Monness, Crespi, Hardt & Co. | |
16.05.2017 | Ashland Global Buy | Monness, Crespi, Hardt & Co. | |
28.11.2016 | Ashland Buy | Deutsche Bank AG | |
27.01.2016 | Ashland Buy | Monness, Crespi, Hardt & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Ashland Global Outperform | BMO Capital Markets | |
16.05.2017 | Ashland Global Buy | Monness, Crespi, Hardt & Co. | |
28.11.2016 | Ashland Buy | Deutsche Bank AG | |
27.01.2016 | Ashland Buy | Monness, Crespi, Hardt & Co. | |
23.09.2015 | Ashland Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
31.01.2018 | Ashland Global Neutral | Monness, Crespi, Hardt & Co. | |
04.01.2007 | Update Ashland Inc.: Hold | Matrix Research | |
03.01.2007 | Update Ashland Inc.: Hold | KeyBanc Capital Markets / McDonald | |
05.12.2006 | Update Ashland Inc.: Neutral | JP Morgan | |
15.11.2006 | Update Ashland Inc.: Neutral | Credit Suisse |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ashland Global Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen